Cancer screening in the elderly population.
This article reviews the current state of knowledge regarding cancer screening in the geriatric population. Care of the elderly requires knowledge of underlying physiologic changes, comorbidities, quality-of-life factors, and life expectancies. There is always the danger that ageism may prevent elderly cancer patients from receiving the proper treatment. On the other hand, overzealous treatment can lead to adverse results if elderly patients are not properly targeted based on current evidence of the benefits and risks of specific screening practices.
Silverman
M A
MA
Division of Gerontology, University of Miami School of Medicine, Florida, USA.
Zaidi
U
U
Barnett
S
S
Robles
C
C
Khurana
V
V
Manten
H
H
Barnes
D
D
Chua
L
L
Roos
B A
BA
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D009369:Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000503:physiopathology